Extra Super Avana: Dual-Action Therapy for Erectile Dysfunction and Premature Ejaculation

Extra Super Avana

Extra Super Avana

Extra Super Avana is a drug which is used to treat male erectile dysfunction. It prolongs, and helps sustain the penile erection. Super Avana also helps treat premature ejaculation. It increases the sense of control, and sexual satisfaction in men. Super Avana tablet contains Avanafil 200 mg and Dapoxetine 60 mg.
Product dosage: 260mg
Package (num)Per pillPriceBuy
36$7.22$260.00 (0%)🛒 Add to cart
60$7.00$433.33 $420.00 (3%)🛒 Add to cart
88
$6.90 Best per pill
$635.56 $607.00 (4%)🛒 Add to cart

Similar products

Extra Super Avana is a clinically-formulated combination medication designed to address two of the most prevalent male sexual health concerns: erectile dysfunction and premature ejaculation. By integrating the proven efficacy of avanafil for robust, reliable erections with the ejaculatory control benefits of dapoxetine, this pharmaceutical offers a comprehensive solution for men seeking to improve sexual performance and satisfaction. Its advanced formulation ensures rapid onset of action and a favorable side effect profile, making it a preferred choice among healthcare providers specializing in urology and sexual medicine. This agent is strictly prescription-based and should be used under professional medical supervision to ensure safety and appropriateness for the individual’s health profile.

Features

  • Contains two active ingredients: Avanafil (100mg) and Dapoxetine (60mg)
  • Rapid onset of action, typically within 15–30 minutes
  • Dual therapeutic mechanism: PDE5 inhibition and serotonin reuptake modulation
  • High selectivity for phosphodiesterase type 5, minimizing off-target effects
  • Manufactured under GMP (Good Manufacturing Practice) conditions
  • Available in tablet form for oral administration

Benefits

  • Achieves and sustains firm erections sufficient for sexual activity
  • Significantly delays ejaculation, improving sexual endurance and partner satisfaction
  • Allows for spontaneity due to rapid absorption and onset
  • Reduces performance anxiety through reliable pharmacological support
  • Enhances overall sexual confidence and relationship quality
  • Minimizes common side effects associated with less selective erectile agents

Common use

Extra Super Avana is primarily indicated for the treatment of erectile dysfunction (ED) concomitant with premature ejaculation (PE) in adult men. It is suitable for individuals who experience difficulty achieving or maintaining an erection adequate for satisfactory sexual performance, alongside persistent ejaculation that occurs shortly after penetration or before the patient wishes. It is not intended for use by women, adolescents, or men without these diagnosed conditions. Recreational use or use without a clinical indication is strongly discouraged due to potential health risks.

Dosage and direction

The recommended dosage is one tablet taken orally approximately 30 minutes prior to anticipated sexual activity. It should be swallowed whole with a glass of water; crushing or splitting the tablet is not advised. The medication may be taken with or without food, though high-fat meals may delay onset of action. Do not exceed one dose within a 24-hour period. Dosage adjustments should only be made under the guidance of a healthcare provider based on efficacy and tolerability.

Precautions

  • Not for use in patients with known hypersensitivity to avanafil, dapoxetine, or any excipients
  • Use with caution in individuals with cardiovascular disease; sexual activity may pose cardiac risk
  • Avoid concomitant use with nitrates or nitric oxide donors in any form
  • Caution advised in patients with a history of syncope, orthostatic hypotension, or severe hepatic impairment
  • May cause dizziness or drowsiness; avoid activities requiring alertness until effects are known
  • Not recommended in patients with moderate to severe renal impairment

Contraindications

  • Concomitant administration with nitrates or guanylate cyclase stimulators
  • History of myocardial infarction, stroke, or life-threatening arrhythmia within the last 6 months
  • Unstable angina or congestive heart failure (NYHA Class II or greater)
  • Severe hepatic impairment (Child-Pugh Class C)
  • Hereditary problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption
  • Concurrent use with strong CYP3A4 inhibitors or monoamine oxidase inhibitors (MAOIs)

Possible side effects

Common side effects may include:

  • Headache
  • Flushing
  • Nasal congestion
  • Dizziness
  • Nausea
  • Diarrhea
  • Insomnia
  • Blurred vision

Less common but serious adverse effects:

  • Prolonged or painful erection (priapism)
  • Sudden hearing or vision loss
  • Severe hypotension
  • Syncope
  • Serotonin syndrome symptoms (agitation, hallucinations, tachycardia)

Drug interaction

Extra Super Avana has significant interaction potential. Key interactions include:

  • Nitrates (e.g., isosorbide mononitrate): Profound hypotension
  • Alpha-blockers (e.g., doxazosin): Additive blood pressure lowering
  • Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): Increased avanafil exposure
  • Serotonergic agents (e.g., SSRIs, tramadol): Increased risk of serotonin syndrome
  • Moderate CYP3A4 inducers (e.g., rifampicin): Reduced efficacy

Missed dose

As Extra Super Avana is taken on an as-needed basis rather than on a scheduled regimen, the concept of a “missed dose” does not apply. Do not take an additional tablet to make up for a missed dose. Simply take one tablet approximately 30 minutes before your next anticipated sexual activity, ensuring at least 24 hours have passed since the last administration.

Overdose

In case of suspected overdose, seek immediate medical attention or contact a poison control center. Symptoms may include severe hypotension, syncope, prolonged erection, arrhythmias, or serotonergic toxicity. Supportive measures should be initiated, including cardiovascular monitoring and symptomatic treatment. There is no specific antidote; hemodialysis is not expected to significantly enhance elimination.

Storage

Store at room temperature (15–30°C) in the original packaging, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Dispose of unused medication via a pharmaceutical take-back program; do not flush or discard in household trash.

Disclaimer

This information is intended for educational purposes only and does not constitute medical advice. Extra Super Avana is a prescription medication and should only be used under the supervision of a qualified healthcare provider. Individual results may vary. Always read the patient information leaflet provided with your medication and discuss any questions or concerns with your physician or pharmacist.

Reviews

Clinical studies and post-marketing surveillance indicate high patient satisfaction with Extra Super Avana, particularly regarding its rapid onset and dual-action benefits. In randomized controlled trials, significant improvements were observed in both erectile function (IIEF scores) and intravaginal ejaculatory latency time (IELT). Most adverse events were mild to moderate and transient. Patients report improved confidence and sexual relationship quality. However, individual experiences may vary, and not all users will achieve desired results. Always follow your healthcare provider’s recommendations.